11 July, 2024
0 Comments
1 category
medicine
Thursday, July 11, 2024
Paris RSV prophylaxis with nirsevimab, which is free for all infants in France, significantly reduced the number of hospitalizations for RSV-associated bronchiolitis during the first major seasonal epidemic. This is shown by the results of a case-control study in the New England Journal of Medicine (NEJM 2024; DOI: 10.1056/NEJMoa2314885). The antibody nirsevimab, which blocks the respiratory syncytial virus (RSV)…
#Nirsevimab #achieves #good #results #everyday #clinical #practice..
Category: Medical Encyclopedia